<SEC-DOCUMENT>0001193125-18-143075.txt : 20180430
<SEC-HEADER>0001193125-18-143075.hdr.sgml : 20180430
<ACCEPTANCE-DATETIME>20180430160950
ACCESSION NUMBER:		0001193125-18-143075
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20180430
DATE AS OF CHANGE:		20180430
EFFECTIVENESS DATE:		20180430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RESMED INC
		CENTRAL INDEX KEY:			0000943819
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				980152841
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-224537
		FILM NUMBER:		18789768

	BUSINESS ADDRESS:	
		STREET 1:		9001 SPECTRUM CENTER BLVD.
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92123
		BUSINESS PHONE:		8587462400

	MAIL ADDRESS:	
		STREET 1:		9001 SPECTRUM CENTER BLVD.
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92123
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d552758ds8.htm
<DESCRIPTION>S-8
<TEXT>
<HTML><HEAD>
<TITLE>S-8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on April&nbsp;30, 2018 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration
<FONT STYLE="white-space:nowrap">No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">S-8</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>ResMed Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name
of Registrant as Specified in Its Charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">98-0152841</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Incorporation or Organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification Number)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>9001 Spectrum Center Blvd. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>San Diego, CA 92123 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>United States of America </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of Principal Executive Offices including Zip Code) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RESMED INC. 2009 INCENTIVE AWARD PLAN, AS AMENDED AND RESTATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Full Title of the Plan) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DAVID PENDARVIS</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Chief Administrative Officer,</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Global General Counsel and Secretary</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ResMed Inc.</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>9001 Spectrum
Center Blvd.</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>San Diego, CA 92123</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>United States of America</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(858) <FONT STYLE="white-space:nowrap">836-5000</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Copy to:</I></B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Regina M. Schlatter, Esq.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Latham&nbsp;&amp; Watkins LLP</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>650 Town Center Drive, Twentieth Floor</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Costa Mesa, California 92626</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(714) <FONT STYLE="white-space:nowrap">755-8261</FONT></B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>(Name and Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)</B></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT>
filer, a smaller reporting company or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; and &#147;smaller reporting company&#148; and &#147;emerging growth company&#148; in Rule <FONT
STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. (Check one): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated&nbsp;filer</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;&nbsp;&nbsp;(Do not check if a smaller reporting company)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION OF REGISTRATION FEE </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Title of Securities to be Registered</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Amount<BR>to be<BR>Registered(1)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Proposed<BR>Maximum<BR>Offering Price<BR>Per Share (2)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Proposed<BR>Maximum<BR>Aggregate<BR>Offering Price (2)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount of<BR>Registration</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Fee</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock, par value 0.004 per share</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">7,392,471</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$95.61</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">706,794,152.31</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$87,995.87</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">The ResMed Inc. 2009 Incentive Award Plan, as Amended and Restated (formerly known as the ResMed Inc. 2006 Incentive Award Plan, as amended and restated) (the &#147;Plan&#148;), currently authorizes the issuance of
19,000,000 shares for grants of equity awards after November&nbsp;16, 2017 (less shares subject to awards granted after June&nbsp;30, 2017 and prior to November&nbsp;16, 2017) of our common stock, par value $0.004 (the &#147;Common Stock&#148;). We
have previously registered 43,733,937 shares of Common Stock for issuance under the Plan (after giving effect to stock splits). This registration statement is registering the additional 7,392,471 shares of Common Stock approved by our stockholders
for issuance under the Plan at our stockholders meeting on November&nbsp;16, 2017. In accordance with Rule 416(a) of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), this registration statement will also cover any additional
shares of common stock which become issuable under the Plan by reason of any stock dividend, stock split, recapitalization or similar transaction. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Estimated solely for the purposes of calculating the registration fee under Rule 457(h) and (c)&nbsp;under the Securities Act, and is based on the average of the high and low sales price ($95.61) of the Common Stock, as
reported on the New York Stock Exchange on April&nbsp;27, 2018, for the 7,392,471 additional shares of Common Stock issuable under the Plan. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Proposed issuances to take place as soon after the effective date of the Registration Statement as practicable. </B></P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are not filing with or including in this form <FONT STYLE="white-space:nowrap">S-8</FONT> the information called for in part I of form <FONT
STYLE="white-space:nowrap">S-8</FONT> (by incorporation by reference or otherwise) in accordance with the rules and regulations of the Securities and Exchange Commission (the &#147;Commission&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION
REQUIRED IN THE REGISTRATION STATEMENT </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration of Additional Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The ResMed Inc. 2009 Incentive Award Plan, as Amended and Restated (the &#147;Plan&#148;) currently authorizes the issuance of 19,000,000
shares for grants of equity awards after November&nbsp;16, 2017 (less shares subject to awards granted after June&nbsp;30, 2017 and prior to November&nbsp;16, 2017) of our common stock, par value $0.004 (the &#147;Common Stock&#148;), representing
an increase in authorized shares under the Plan of 7,392,471 shares. We have previously registered 43,733,937 shares of Common Stock for issuance under the Plan by (i)&nbsp;a registration statement on form <FONT STYLE="white-space:nowrap">S-8</FONT>
filed with the Commission on January&nbsp;31, 2007, registration no. <FONT STYLE="white-space:nowrap">333-140351,</FONT> covering 15,600,000 shares of Common Stock, (ii)&nbsp;a registration statement on form
<FONT STYLE="white-space:nowrap">S-8</FONT> filed with the Commission on December&nbsp;11, 2008, registration no. <FONT STYLE="white-space:nowrap">333-156065,</FONT> covering 4,200,000 shares of Common Stock, (iii)&nbsp;a registration statement on
form <FONT STYLE="white-space:nowrap">S-8</FONT> filed with the Commission on January&nbsp;26, 2010, registration no. <FONT STYLE="white-space:nowrap">333-164527,</FONT> covering 3,121,650 shares of Common Stock, (iv)&nbsp;a registration statement
on form <FONT STYLE="white-space:nowrap">S-8</FONT> filed with the Commission on May&nbsp;12, 2012, registration no. <FONT STYLE="white-space:nowrap">333-181317,</FONT> covering 12,553,350 shares of Common Stock, and (v)&nbsp;a registration
statement on form <FONT STYLE="white-space:nowrap">S-8</FONT> filed with the Commission on February&nbsp;27, 2014, registration no. <FONT STYLE="white-space:nowrap">333-194225,</FONT> covering 8,258,937 shares of Common Stock (collectively, the
&#147;Prior Registration Statements&#148;). The contents of the Prior Registration Statements are incorporated here by reference to the extent not modified or superseded by the Prior Registration Statements or by any subsequently filed document that
is incorporated by reference in this registration statement or in the Prior Registration Statements. The amount of Common Stock registered under the Prior Registration Statements referenced in (i), (ii) and (iii)&nbsp;has been doubled to reflect a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">two-for-one</FONT></FONT> stock split on August&nbsp;17, 2010. This registration statement is registering the additional 7,392,471 shares recently approved by our stockholders for issuance
under the Plan. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Interests of Named Experts and Counsel </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;8.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Exhibits </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See Index to Exhibits included herein. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEX TO EXHIBITS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center"><B>EXHIBIT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Certificate Evidencing Shares of Common Stock (incorporated by reference to the Registrant&#146;s registration statement on form <FONT STYLE="white-space:nowrap">S-1</FONT> (No.
<FONT STYLE="white-space:nowrap">33-91094)</FONT> declared effective on June&nbsp;1, 1995)(P)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;5.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d552758dex51.htm">Opinion of David Pendarvis</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d552758dex51.htm">Consent&nbsp;of&nbsp;David&nbsp;Pendarvis&nbsp;(included&nbsp;in&nbsp;Exhibit&nbsp;5.1)</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d552758dex232.htm">Consent of KPMG LLP, Independent Registered Public Accounting Firm</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#sig">Power of Attorney (included in the signature page to this registration statement) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/943819/000119312517293062/d456787ddef14a.htm">ResMed Inc. 2009 Incentive Award Plan, as Amended and Restated (incorporated by reference to Appendix B to the Registrant&#146;s Definitive Proxy
 Statement filed on September&nbsp;25, 2017)</A></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Filed herewith. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(P)</TD>
<TD ALIGN="left" VALIGN="top">Paper exhibit </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the requirements of the Securities Act of 1933, ResMed Inc. certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing on form <FONT STYLE="white-space:nowrap">S-8</FONT> and has duly caused and authorized the officers whose signatures appear below to sign this registration statement on its behalf, in the City of San Diego,
State of California, USA, and in the City of Sydney, State of New South Wales, Australia on April&nbsp;30, 2018. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>RESMED INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael J. Farrell</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Michael J. Farrell, Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brett A. Sandercock</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Brett A. Sandercock, Chief Financial Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>POWER OF ATTORNEY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each person whose signature appears below hereby authorizes and appoints Michael J. Farrell and Brett A. Sandercock as <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, each acting alone, with full powers of substitution to sign on his behalf, individually and in the capacities stated below, and to file any and
all amendments, including post-effective amendments, to this registration statement and other documents in connection with the registration statement, with the Securities and Exchange Commission, granting to those <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents full power and authority to perform any other act on behalf of the undersigned required to be done. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the
capacities indicated as of April&nbsp;30, 2018. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:33.30pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:15.95pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael J. Farrell</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Michael J. Farrell</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director and Chief Executive Officer (Principal Executive Officer)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brett A. Sandercock</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Brett A. Sandercock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer (Principal Financial and Accounting Officer)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Peter C. Farrell</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chairman of the Board</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Peter C. Farrell</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Carol J. Burt</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Carol J. Burt</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Gary W. Pace</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Gary W. Pace</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Karen Drexler</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Karen Drexler</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Richard Sulpizio</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Richard Sulpizio</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ronald Taylor</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ronald Taylor</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John Wareham</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John Wareham</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d552758dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g552758g0427104855414.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April 30, 2018 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ResMed Inc.
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9001 Spectrum Center Blvd. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Diego, CA 92123 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Board of Directors </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Re: Registration Statement on Form <FONT
STYLE="white-space:nowrap">S-8</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As the global general counsel for ResMed Inc., a Delaware corporation (&#147;ResMed&#148;), I render the following opinion in connection with ResMed&#146;s
proposed issuance of up to 7,392,471 shares of its common stock, $.004 par value per share (the &#147;Shares&#148;), under the ResMed Inc. 2009 Incentive Award Plan, as Amended and Restated (the &#147;Plan&#148;), and the registration of the Shares
by a registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> under the Securities Act of 1933, as amended (the &#147;Act&#148;), to be filed with the Securities and Exchange Commission (the &#147;Commission&#148;) on the date
hereof (the &#147;Registration Statement&#148;). I am furnishing this opinion in accordance with the requirements of Item 601(b)(5) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Act. I am not expressing any opinion in this
letter as to any matter pertaining to the contents of the Registration Statement, other than as to the validity of the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this
opinion, I, or other employees under my supervision, have made legal and factual examinations and inquiries of the documents, corporate records and other instruments that I have deemed necessary or appropriate for purposes of this opinion. In
examining these documents, I have assumed the genuineness of all signatures, the legal capacity of all natural persons, the accuracy and completeness of the documents submitted to me, the authenticity of all original documents, and the conformity to
authentic original documents of all documents submitted to me as copies (including PDF files). As to all matters of fact, I have relied on the representations and statements of fact made in the documents so reviewed, and I have relied, without
independent verification, on certificates and other inquiries of officers of ResMed. I have obtained and relied on certificates and assurances from public officials to the extent I have deemed appropriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I am opining in this letter as to the effect on the subject transaction only of the General Corporation Law of the State of Delaware (&#147;DGCL&#148;), and I
express no opinion with respect to the applicability or the effect of any other laws or as to any matters of municipal law or any other local agencies within any state. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the foregoing and the other matters set forth herein, it is my our opinion that, as of the date hereof, when the Shares shall have been duly
registered on the books of the transfer agent and registrar therefor in the name or on behalf of the holders and have been issued by ResMed for legal consideration in excess of par value in the circumstances contemplated by the Plan, assuming in
each case that the individual grants or awards under the Plan are exercised in accordance with the requirements of law and the Plan (and the agreements and awards duly adopted thereunder and in accordance therewith), the issuance and sale of the
Shares will have been duly authorized by all necessary corporate action of ResMed and the Shares will be validly issued, fully paid and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">

<TR>
<TD WIDTH="90%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>ResMed Inc</B>. 9001 Spectrum Center Boulevard San Diego CA 92123 USA</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>T</B> +1 (858) <FONT STYLE="white-space:nowrap">836-5000</FONT> <B>F</B> +1 (858) <FONT STYLE="white-space:nowrap">836-5518</FONT> <B>E</B>
reception@resmed.com</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"><B></B>&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right"><B>ResMed.com</B></TD>
<TD NOWRAP VALIGN="middle"><B></B>&nbsp;</TD></TR></TABLE>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g552758g0427104855414.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">nonassessable. In rendering the foregoing opinion, I
have assumed that ResMed will comply with all applicable notice requirements regarding uncertificated shares provided in the DGCL. I consent to your filing this opinion as an exhibit to the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ David Pendarvis </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Pendarvis </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Global General Counsel </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">

<TR>
<TD WIDTH="90%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>ResMed Inc.</B> 9001 Spectrum Center Boulevard San Diego CA 92123 USA</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>T</B> +1 (858) <FONT STYLE="white-space:nowrap">836-5000</FONT> <B>F</B> +1 (858) <FONT STYLE="white-space:nowrap">836-5518</FONT> <B>E</B>
reception@resmed.com</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"><B></B>&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right"><B>ResMed.com</B></TD>
<TD NOWRAP VALIGN="middle"><B></B>&nbsp;</TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>d552758dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g552758kpmg.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consent of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ResMed Inc.: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the use of our reports with respect to the consolidated financial statements and the effectiveness of internal control over financial reporting
incorporated by reference herein. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:54%; text-indent:-2%">


<IMG SRC="g552758kpmgllc.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Diego, California </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2018 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g552758g0427104855414.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g552758g0427104855414.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !\ QT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !6#XF\3V_AR&$O$TTTQ.Q <<#J3^=:FHW\&F:?->7!(BB7<<=3[5P-SJ6E^
M/+N"QF26RN5+?9Y<@AO53^7Z5TX:CSOGDO=6YR8K$<BY(.TWL1S^'X/']Q_;
M5G=&U8XBN(G7<5*CJ/PQ7HMG:I964%K'DI#&L:YZX Q5'P_H5OX?T[[+ S.6
M;>[MU8UJTJ];G?+%^ZMBL-0Y%SR7O/<****YSI&O&D@ =%8 Y 89YKA+%H_
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F%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g552758kpmg.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g552758kpmg.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MSC3C%-V25VKV270^H*^5/I0H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@#Q_XX_\ (EZ)_P!E@_9Z_P#5_?#.
MO9R'_?J__8NS?_U4XT\G.O\ <Z/_ &'Y5_ZL\&>P5XQZP4 >/?%7_D-?!3_L
ML-C_ .H!\0J]G*?X&>?]BZ7_ *EX0\G-/XV3?]A\?_47%&/^R[_R;I\%/^R;
M^%?_ $UP5OQ5_P E)GG_ &&U_P#TXS'AG_DG\F_[!*'_ *0CWFOGSW#S?XR?
M\D@^*O\ V3?QS_ZC&J5Z>2_\CG*?^PW"_P#I^!YV;_\ (IS3_L$Q/_IF9YM\
M"_\ D=/CY_V.'PU_]4#\*:]//O\ <>'O^P?&_P#JVQYY^2?[YGO_ %_PG_JL
MP1](U\R?0A0!\3>!/^2X^!_^PS^VM_ZM/X95]SC_ /D0X_\ Z]\-?^H.-/C<
M#_R.L%_U\XA_]3<&?;-?#'V04 >#0?\ )SVI_P#9!M"_]6#XBKWY?\DM2_[&
MM7_U$HGAQ_Y*6I_V+*?_ *E53WFO /<"@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /F?]KOQB/A_\"M;\:+;
M0W]QX5\9?"/Q+9Z9/<FT75;GPY\7/ ^OKIPN%CD:'SHM,E#.L<A1 [A6V8KZ
MC@[!?VAGU# \SIQQ>&S"C*:CS>SC6R_%4>>UU?E<U9-J[LKJY\YQ7B_J&25L
M9RJ<L+B,#6C!NW.Z6.PU7DO9VNH/5)V5W9V/._V9OVN;KXX>'_B-XR\8>%-%
M^&W@SX>0Z:UWX@G\1S7UK/-<PW]W?K))<Z9:);1V-G:6SR$LS,=2MU122<>E
MQ1P=#(,1EF"P6+J9GC<Q<^6BJ*A)*+A&%E&<W)SE*26B2Y)-M'G\-\5RSK#Y
MAC,7A:>78/+U#FJNLY1;:E*5VX045",4WU?/%)'S\G_!277O%7Q#'@CX4_!4
M^,DU77#H_A%[GQ-<:;JNN1[BD-]<6 T22/2XI$CDN7$T^VV@!:XD412,OT+\
M,L/@\M^O9MGGU)T:7M,0HT%.G2>[@I^U3J--J"M&\Y:03ND>"O$2OBL?]2RO
M)OK:JU/9T&ZSA.HME)Q]FU!-)R=Y6A'635FSWG]K?XT:C\%_A]\'?&OB#1-)
MO_&MI\1=.U1_"FG:M<#2I)X/!WBNSU>*WUB>P6XEL;)M8MHQ<FQ5I'DAS#&L
MI\OP.#\CI9WF.<X'#5ZE/ RP<Z:KSIKVB3Q%"5-NFIN*E/V<GR^T:BD_>DUK
M[G%6<5,FP&48RO1A/&0Q<)NA";Y+K#UXU$JCBI.,/:)<W(FVU[J3T^(_AK^W
MW\1O /PI\&^&M&^"":OHG@K0M,T"3Q5/J&NOI][;:1;I92S.]IH@M[&=I%3.
M;F98SE2&)!'W.9^'N6X_-L;BJV>^PKXVK.JJ"A24X.H^9)*57FDDK_9BWOH?
M&9=QUF&!RO!X:CDOM:."I0I.LY5.22IKE;]VGRQ;:_F:6VI]D_LO_MS:-^T#
MXMG\ :SX-?P5XH;3KS4]&:#6AK>EZU#IX66]M%>33K*:QU&*U9IUC*7$<D5K
M</YL;(L;_%\5<!5N','',*&-6.PJG&%1.E[*I2<](RLISC*#DN5N\6I2BN62
M;:^OX:XUHY]BG@:N#^I8GDE.G:I[2%10UE&[A"49J/O)6DFHR=TTD_FSXY?\
M%%9UO_BQ\*M'^'&G:CHN[QGX M?%#>)[B.6ZMVCU#P\^M16$>C/&8V8R7$4?
MVCYDV992QV_39#X;15/*,VK9G.E77U;%RH>P346G"LJ3FZB=UI&3Y='?1V/G
M<Z\0)*>:971R^%2C_M&%C6]LTVK2I.HHJFU;>45S:JVJ/J#]AKXES_%[1?B[
M\0;G2(M"FUGQ[X>M&TN"\>_BMQX=^%_@;PPCK=26\#2&>/1EN"#$NPSE 6";
MF^5X\RN.35\FRZ-9UXT,)6DIN*@W[;'8JNURIRMRNIR[ZVOI>Q]+P5F,LUHY
MKCY4E0=;$TH\BES)>RP>&HKWFHWYE3YMM+VUM<Y/]I/]OO3?@A\0Y/AYX6\(
M6/CJ^TBQA?Q/>RZ_)I5MI.K7/[V+18?L^FW?VFZALS#+<'<HB>Y6$_O8IEC[
M.&/#VIGN6K,<5C)9?3K2:H05)3E.G'1U7><.6,I74-^91<OA<6^7B+CJGDN/
M>7X7"1QTZ,5[:3JN"IS>JIJT)WE&-G+;E;4?B4DK/[+W[;?B']HOXDS>!7^&
MNF^&K*Q\-:GXDO\ 5K?Q)=:I+#!876G6$,2VLFCVRDRWNJ6J;C+P-Q /:.*N
M!L-PUED<>LSGB9SK0HPINC&FFY1G-OF523]V-.3M;YE<-<9XCB#,7@?[.AAH
M4Z,ZTIJM*;2BX12Y73BM93BMSQ'XH?M/>'/@7\1M,U&PLH/&/BOPYXD_:JT^
M_P##,.H&P729?&_Q,\*W'AZ[UF\6UG\F*2#POJDWV6-6G9%@+"&.ZBF/NY5P
MMB<^RVK2J5'@L'B:.0SA6<.?VBPN"KJM&G'FC=IUZ<>9OD3YOB<)1/%S+B7#
MY'F%*I3@L7BL/5SJ$J*ER>S>(QE%TI5)<LK)JC-\J7,UR_"I*1X[<?MV_MA>
M-H-0UGP7X5L;+0K1Y!+=>$OAUJGB"QTU+=?.D6[U+4VU2-9EMP&E:0QK@LZQ
MQ+@+[4> >#,#*G0QN+E.O)*T<1C*=*4[Z+EA#V3M?2*5WT;DSR9<;\6XV-2K
M@\+&%"-[RH82=6,+:OFG/VJNE\3=EU2B=-\(?^"F'Q"M?$VE:;\7='\-ZSX4
MO[VVM-1US1;&?1=<T2&XE2)]3\J.ZELM1M;96,KVHMK>1U5MLX("MRYQX7Y=
M+"U:N3UJU#%TXN4*562J4JK2;4+N*G"4ME+FE%.UX]3HRGQ&Q\,32I9K1HUL
M+.2C*I3BZ=2DFTN>RDX2C'=QY8MK:70_3Z#_ ).>U/\ [(-H7_JP?$5?E<O^
M26I?]C6K_P"HE$_2H_\ )2U/^Q93_P#4JJ>\UX![@4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^3O\ P5)^
M(/V/PU\./A?:S;9-9U6^\9ZQ$A*NMGHL#Z1HT<N& >WN+O5-5DV$$>9I,;<%
M%S^N^%&7<^*S+-9QTH4X8:F^G-4?M*C79QC"FK]JC75GY;XF8_DPV799!V=:
M<L147]VFO9TT_*4IS=N\$^A^9>D^-_'/BCP)X5_9Y\"V-V=/USQ5)K&JZ/I8
M!O\ QSXTU2Z@L])-_)O .F:?IMCI$4%J[)"D\$][.Q*PFS_4:V P&#Q^+XCQ
M]2*J8>@J=.I/X,+AJ<7*IR+^>I.51RDKR<7&G%?%S_G%+&XW$X'"\/X&$O9U
MJ[J3IP^+$XB;48<S_DIPC!1B[14E*I)_#R?N-^R1^R1H/[/>@KKNNK9ZW\5=
M;LU36M:11+:Z!:RA7?P[X==U!2V5@HN;P!9+N2,$A84BB3\'XPXPQ'$6(^KX
M?FH930E^ZI;2JR6BK5DOM?R0U5-/K)RD_P!IX4X5H9!05:LHULTK1_>5-XTH
MO7V5+LE]N>CFUTBDE^>'_!33XA?\)%\9?#_@*UG#V7PZ\,QM=0AE/D^(?%A@
MU6^!"\@G0[;PT<,<@EL  Y;](\+LM^JY)B,PE'EGF-=\K[T</>G#_P JNMMY
M?+X#Q'Q_UC-Z&!C*\,OHKF7:K7M.7_E.-'<]A^'?[9OP/^"O[+_AWP%X2N]5
M\0?$/3?!MW'_ &2GAZ^M].A\:>(/M6IZC)J6I:I#%;W.F6>M:I<!VA-P98;0
M)$A5DQXN9<$Y[G?%6)S#%PIX;+:F)B_:>V@Y_5J/+""A"FW*,YTZ:LGR\LI7
MD[IGKY?QADN3<-8? X6<Z^84\/)<BI24%B*O-.;G.:490A4F[VYKQC:*LT?*
MW['6EZSX,?XH_M&36LMIX=^$GPX\5+I.J7"-%::CX^\0:?\ V-X<T2U>1/+N
MG+WK&?;YGD&XL_,7-U%N^LXSJT,:LJX:C)2Q.;XRA[2FM90PE&?M*U626L=(
M^[>W-RSL_<E;Y?A&E6P3S/B!Q<</E6$K<DWI&6)JQ]G2IQOI+67O;\MX77O(
M^:?"G@JY\3^%/BOXOE:8VWP_\,:'K4ER6+";5?$'Q!\)>%K6UF8DEGFLM9UB
MX!.<FP.3G&?J,7CHX3%Y1@HI*685ZM)1[4Z.$Q%>4EV494Z<?^WSYW"X.6)P
MN:8IWY<!1IU&^\ZN*H4(Q?K&I4E_VZ?>_P"RS\>-/_9^_9,^+'BK=!-XIU/X
MCS:'X'TR4"07GB*Y\):(8KN>'^/3M.A#WMQDJKK;I;AUDNH\_GW%?#]3B'B_
M*,)9QPE'!*KB9K3EHQQ%6\4^DZCM3ANTVYV:A(^YX8SRGD/"N:8FZ>)J8MT\
M-!_:JNA3M)K^2FO?ELFDHW3DCXMM_ FM^(?AI\0OCMXNN[V6V;Q/IOAK1=1O
MI)'N/%?Q \17S:SK4KSOS=1V/AZTU>ZN&#!C<WUE]]%G5?MY8^AA<SRW(,%"
M,9*A.M4A%)1P^$HQ]G222^%SK2IP@K6Y(U-FXM_'1P-:OEV/SO%2DX^VA1IR
MDW>MBJLO:5'=_$H4HU)2Z\\H;I21]H?L(:K;?"?X4_M*?'Z_MDG/AC0M)T'0
M4<-LN=5"7EZ=.E(9<0W6KWOA*)F5LJKLWIGXGCZC+-LVX8X=IR<?K56I5JV^
MS3O&/.O.%..(:ONTD?8<#U8Y7E?$6>SCS?5:=.E271SM*7(_*525!/LKGRQ\
M!/A_JG[3'[0FCZ/XKO[N^7Q-K>J>+O'VK;O*NKC3;9IM9UUEDA4?9;B_G*V,
M3QH%AEU*)@H2/ ^KX@S&EPOPY6K82G&G]4I4\/A*>\8S=J=+1_$J:_>23=Y1
M@U>[/F<BP%3B//Z-'%3E/ZQ4G7Q,]I.$;U*FJ^%S?N1:5HN:=K(_;+XG_M1?
M G]EK4?#_P +-4TG6].6U\,V.I:3HW@S0=/GTO2=&EO-0L+.W<2:G:"WN&ET
MZZD,85V*NDKDF8%OPW*N%,_XJI8C-:-:E4YJ\H5*F)JS52=11A.35H3NDIQ5
M[I73BE[NG[)F7$N2<,U*&65:52GRT8SA3P]*+A"FY2C%:SA9MPD[6;M:3^(^
M'/";_P#!/;XO_$K3/#^C_#?XGR>*?'?B63R$EGU&PTA=0U*YFOKB26"R\8/'
M9:9%F:1DA@*111D*FU0*^\Q:\1<ERNKB*V9X&.$R^BKV4)U.2$5"*3EATY3>
MB3E*\I/5W9\7A7P%FN8TL/1R[&/%8VL[)N<*?/-N3;4:[48+5M*-E%:*R/TG
M@_Y.>U/_ +(-H7_JP?$5?F,O^26I?]C6K_ZB43]$C_R4M3_L64__ %*JGO->
M >X% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 ?SS_M1ZC>?M _MF7?@S1[@RVZ>*/#GPCT65<.+./3KR/3];
MG)R5,$'B*]\0W)8<",9.<$G^C>%*4.'."88VM'EE["MF%1;<SG%SI+UE1C1A
M;>Y^!\35)Y]Q?+!T97BJU' TW_*H24*C](U9597['!?M4?!N\_9L^.,]CX4F
MU+2= N7LO&7PYU2VO[V+4-,M#<EDMK?5HYA=1:CI&L6L\$<XN#<B.&TN6<23
MAJ]#A/.H<39#&>+C"MB(\V&QE.4(N$Y<MN9TVN1PK4Y*3CR\EW."5HV.'B?*
M)\.9TZ>%<Z-"7+B,).,I*4(WT2FGS*=&I%Q4N;GLH3;O*Y^S'P:T?X9?%CX1
M^%?BA#XB^*UI;ZIH0N]?B'[1/Q^6#1=8TR-X/$EC(9/B:6C@M-1M;P(\FTO
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M&'LU.4W*]M6['[2_\,$?LF_]$H_\OKXE?_-C7XC_ ,1!XO\ ^AO_ .6N"_\
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M:B\7>-/%7B33KK6M0CC\1/H;V4VJZY9WUG=ZG<I8Z1;O)=*-1NI8SO 69DD
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M7[9YGV__ (374/'5A]B^P_95^R_8O^$*\SSOM$WG?VEM\N+[/F<#8\2\6_M
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MT_8-'\$?$;P1>Z(+>0'5;/XAW/@F6YN!J<5Y&]@;6'P>\6Q(9&E_M3>)83;
M3FWR%L>#6O[+6JZGH3^'OB#\4KGQ7:Z'\)M7^#_P\O=(\*IX5U3POHNJWF@W
MA\3:U.WB/5(/%'CB)_"'A!/MT-MH]DZZ(X?3O].GW&WR*O;I8]<^''PU\2^&
M?$?BGQSX]\:V/CKQOXHT;PGX8EU'1_"DG@O0M-\-^#?[;N=-L=/T&?Q+KTL5
MY<ZMXEU[4+VY.HE)I;V-(;>VAMHXP;?(3?1:)'L= @H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@#Q?XV_%73?AEX>L(6U_PYX=\2>,+V;0?"^I^+-1L-,\.Z+/'9S7VK>+
M?$%SJ-W;0+H.@:5#/J$\3SPF[ECM-.BD2XU*$T;?(:7X'QOI_P 3/B!\;],_
M9]\,^%-9G^(UUJ_PF\;^,_'NH^%_C+=?!.UU#Q5X<O/!F@C^W?&?PIT6]U&P
MN].N/$4A;PYIFGV\$UYK^GS7PAL]/=)#\+%6M?I9Z:?H,C^)_P <KSP_9>.=
M$\5>/)OA=\/?@3X"\9>-[RWUCX-Z+XMO+ZRO/'<OQ!NKFQ\2_"'QH_BOQ-%H
MN@V#+;V^J^$K"9=+F>"[DNM0&TV\@LETUOIO\NJ/2X/'WQBL_BC>>*M?UWQ&
MOP5G^-6B_#;0[32-8^&$-KY7B5-&T'PV]SX5NO@U>>(K_0YO%VJ6MK>WZ_$+
M3M0@EU LFFBUL92QL*RM;JE_77]#M_CY)J5W\3_A%H$.A_%[Q9I-_P"$/B[J
M>H>%OA!\3;CX8:M<WND:G\)[?3-9U34T^*7@.'4+&PBU?4X%MY-6N'5]9WQV
MKCS)(#;Y"6E^EOZ\S9U;XLW'PL;X=^"9? 7B&&X\>Z9;:1\.;/Q?\0CK_B.X
M\;)<V_\ :'A+X@^(KF^\2-I_V33+T:@=?BUSQ0ES'IM_:Q![[^S+36C;Y!;Y
M6.(TW]KU;KQ<]E=_#+Q-:?#[_A(?&OAF'QY#I'Q,N ;SP/;^(FOM3=[KX3V?
M@^;0+N\\+:I;6TMAXZU"^W/;&XTZ B[2P-OD/E_#I_3.TTGX]>*ETO1M3\7_
M  RL_#<?BI_A??\ A9+#QY!XA$GA[XE?$;PIX!,OB.3_ (1BP_L3Q-I,?B[3
M=3ETVR76;"=<V\6LAP\D1^@K6^1F_$'XQ?$2'QA9^&/ 'AWPT8=!^.OA+X:^
M);W7O%MUILNK6&O_  U\/_$&-+2TM_ .M"SCEC\07-M+()TFA.B6SQ-(NJ2#
M3#;Y E^0ZT^/^F>%-(UW^T?"VK6]E::/\3M?\(&Z\8:EXGU'QIK_ (,^*VN^
M!]8\'6M]X@M_.L-4N]9O?![:7:/=W$,</BL6-M'!::$#(?H%C)L/VI]3O/B+
M%X0/PJUX>'8?']K\+]4\6V5G\3-1@L_%AFMM(U.YMM0M_A /!EQX6L?%4TNE
MO>W/CFQOR+26X;2H\I"YM\A\MEN==\0?#4?CGXV^%O"6J>(O'^D:&OPD\<:X
M+3P1\2?'WP]W:U;>+? NF6>IW3^!_$>E'4I[:SU*]2)+[[3$OVASY9S1M;R$
MM%Z'%>!OBE\1M$^P_#JQTZ+XK:M;_&'XB_#6P\7>+_%<?A6X7PIX)TZRU]=8
M\1ZAI'A#5!KFLV5I>W&B2/;:=;O=WNE1O/Y;3W,\)M\AV^5C8T_]H*S\.^'+
MW[1X1U2.4^$+CQ+\/K"\\9ZAXBU#Q]KDGQ O_ <_@V#6M?M#=6VJIXLU+P3;
M1F62]1(?'.GI$BI9F*C85OP*'@_]JB^\4_$+2?"W_"KO$%GX2UOQAXD\"6'C
M>+3_ (FSVIUSPS_;MM<7\EY??"*P\(3>&KK5?#FI6EO<V/C:]OOGMWN=,MB+
MN/3S;Y#Y;+TZ?TSZ_H)"@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * /(=7^!/POUK0/"?AJZT+4K33O MG>:=
MX2N=!\7^-/"^OZ'IVHVL=EJ>G6?BSPUXAL-;_L^^M(88KNVDU!XKI;>(7"2>
M4FTV\K#NT4]5_9W^#VKIH\%UX1:WL=#\/Z+X4@TC2/$7BKP_H6I^%_#L\EUH
M?AWQ3H&A:Y9Z=XTT.RN)[EX;'Q!:ZG IO+GY/])E\PV\K!=HUYO@K\-I_&<?
MCV70;L^((M:B\3+ OB7Q5'X6?Q1;Z<VDP>*I_ <>MKX9N/%<>GL(5UJ72'OU
M"1L+@/&C*;?(+M:%_P ;_"SPA\0+[0M4\0KXHMM4\-6^L6>C:IX2^('C_P"'
MNIVMGX@?29-8LI-0\ >)M&N+VSNI="TAW@NI)HP]A$RJK DFWE8$[&;=?!/X
M<7]A<Z=J^DZOKL=UX?LO##WOB3QGXV\1ZY!I.G:N?$%D;#Q%KOB*[U73-5BU
MP6M^-6L[R#4#<:7IDK71?2K(VIM\@O;RL1Z7\#/A?H_B>7Q;8^'+C^UI=0U?
M5UMKSQ)XJU3PW::WXAM+BQ\0:_IG@S4];N/#^D^(-4M+R_COM4LM,@O+L:E>
M_:)Y#>W!F-OD%WMV,G3_ -G#X.:9HGB#P[;>%;R32/$FE:=H-Y;7_B_QMJLF
MF:%HVH2ZMHVB>$;W5/$=Q<^ ](T[59?MME9>&YM)@M+F&">W2*6VA>(V"[^X
MDL_V>/A1I^C7VAVFC^(8[?4O&EA\1+_47^(OQ(G\3W/C;3=/L]*M/$4GC*?Q
M:^O_ &\:=86MO)C4@DR*XF23SI/,/T"[^XZ2]^$/PYU&'PK!?>&+:[C\$>-K
MWXB^%_/O-3=]*\8ZAJFJZW=ZNDIOM]RKZQK-]>"SN6FM$F%K(D"M86AMC;Y!
M>Q47X+?#=/&K^/UT*\7Q"^LKXD>#_A)O%?\ PBQ\3II0T1?%)\!?VW_PC'_"
M5#3!Y(UG^Q_M_5_M'F$N3;Y!=K3:Q8\;?"/P5X_U73=;\0+XLMM7TG2]0T6S
MU'PE\1OB+\/KO^R-5N;*[U#3;R7P#XJT8ZE9S76FV,IBO//56ME*A><GZ G8
MTM"^&O@7PS;>$[+P]X;L=&L_ Z:HOA>UT]KFUM],.MQ21:Q,T,<X2_NKWSII
M)[B]%Q+)-/+.SF>1Y&-OD*Y0F^$/PYN/^$'\_P ,P3'X;:Y>>(_!32WVJN^B
M:QJ'VPW=TLC7Y:_C>6]EF^SWIN8%FBM9TB6:RMG@/T'=KR*>E?!7X:Z)XOD\
M<Z;H%S!KS:MJ_B"&-_$?BFZ\.:=XAU^">UUWQ%HO@N[UJ7P]H/B'4;>[ODN]
M4T[2[6[N!J%YYTSF\G,IM\@N]NQZI0(* "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@#PCX]^%]!\9:1X%\.:_J6@
MI!=_$?1+JS\(^+6ND\'_ !.O=,TK7;Y/A]XD-LDBR6EU!#<:G!#/!?0O>^'K
M,S6&H0I)9W!M\AK0^<I/BO/\.]+/P\^ OA71['7(/'_Q-MM>\+0Q:5XO\'^#
MX_ WAWPEK_BFW\!6^I?$#X8Z+;^$89/&/A^>83>(-(_LRZO]4M4TN:YBDMK0
MV^0[=^EOZZFTW[0?Q@U3PC/\2]$M/AQIGA'PY^SS\(?COXAT+5="\2ZKX@UI
M_'6F>)];\1^%=$UFS\86%KHGV73/#;BSU&[TS4AY]U&DUM(F^2,_0+):>;7W
M'L?[07A[P_XKD^"?A[Q3H>C^)= U/XV:3%J6AZ_IEEK.CZA%%X!^(EQ''?:9
MJ,$UM=QI<0Q2*LL; /$C ;E! ):7Z61XI8)X3^'OQ,^(/A#X;Z/X9U'X<:?X
MJ_9H-WX4GB&K^#_A]\4_%GQ4UO0O$,7A'25N1:^$]?M?#<'A/6%L+%8H=,OH
MM-O%MXVNV28V'T72USG]*_:T^+L=C>^.-=^&5K_P@>I>$_C)XH\+Z=;Q^$['
M6(D^%^BZYK=K:2ZM8_&G7M9\0W$W]CP:9J<4WP]\+-IE]JT4<N3&$N#8.5+K
MM;^MOU.HU?X^?%_P;JD_AW7]8^"'B>_UCPM\+=7\/:_X9TSQ/HOAWPY>?%#Q
M]I_@BWU'Q=%>^-M7DOO"5B+N2[MKZVNM-?5\11JNG;RZFWR!)>:M^A]!?"?Q
MMXLU_5_B1X/\:7?@_6=>^'/B/3-(F\1>!;+4M(T35(-:\/V'B"VM[OP]JVN:
MW<>'?$%C'>B&ZLFUG4E9'M+I9(A=^1 ;?(35K=#@?B/X?\)>.OV@/ W@GXHZ
M?IGB#P8WPV\2Z]X-\'^*+:VN_"7B7QW:Z]IEIK=Q<Z1?JUEXFUW1_"\UK+:V
M5W'<_98=5O[V&$/&T]N?H"T6FAXY\5Y_A=>^"? /P \*ZMXWUCX:>*];\>ZM
MXAN_ F@?$7XGZOH/A#P)K>H)#HFBQ^ M$U35+/0K3XJ7?AW3+&XD!L8K'PS>
M:?%.ZQQA0:NM=FOD>OZ!XZUSXG?LG>(M:E\20^!/'B?#;QQX6\1^)=?6[\(1
M^#?B!X:TG5O#NL^(-:@U^WL;SPE:P:S8MJ^-1@M9K2TGAEE52N2;?(5K/TZ'
MSYX3\.^"H_'7C7PAJ_PQ?X'?"$_!KP3KOQ"\,Z=XH\,747B?7M,\;V;:!>ZQ
M:_#K7=9M[ZW\46<6LZ.))YAK?BJUM+BWO+8?N(YS;Y%=%U:>A['IGPTU#P7\
M _C-+HTNM?"*U\0WOCKXE>&O!W@J6P\/S> =$C\*6MKI7A:SDM;24>&Y+XZ
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g552758kpmgllc.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g552758kpmgllc.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( "( H0,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /W T[XG_#[5?'NN_"W3?%VB7GQ"\,Z7::UKWA*"[5]8TO2[
M[[.;:[NK<#"HRW=FQ4,61;RW9U59XRX!WE 'Y]?MF_MW>"/V=-"U'P;X,U/2
M?%GQ]U5+33O"_@V)Q=6VC7VJ7*6<.I>*)XW6"Q%NCO,EA-,DTS" 2+'!-YM
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M-I%>=@BLD=N5\P@%70O^"0/P2N]!L;CXE>,?'7B[XCW-U<:IXI\9V^LSV/\
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M^*O#LND:G<R>&])T_1Q;WZ&V1EG79')<0!0V.&A(213N5: /U&_8Z^#?BWX
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K2*)5 55C1550%"A5   '   Q@4 24 % !0 4 % !0 4 % !0 4 % '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
